Literature DB >> 864506

Cerebral perfusion, vascular spasm, and outcome in patients with ruptured intracranial aneurysms.

P J Kelly, R J Gorten, R G Grossman, H M Eisenberg.   

Abstract

In a retrospective study of 44 patients with verified ruptured intracranial aneurysms, the results of radionuclide cerebral perfusion scintigraphy (dynamic brain scanning) and the presence or absence of arteriographic spasm were correlated with the clinical outcome. The data indicated that patients with normal dynamic scans had a better outcome as a group and following intracranial surgery than those in whom perfusion was reduced. Patients with normal perfusion had a higher incidence of preoperative rebleeding from their aneurysms, while patients with reduced perfusion had a higher incidence of infarction, especially after intracranial surgery. There was no correlation between the presence or absence of arteriographic spasm and the results of the dynamic scans, and nor correlation between the presence of absence of spasm and the outcome of the group as a whole. However, in some individual cases with severe spasm, reduced perfusion on the dynamic scan and a poor outcome were noted. It was concluded that the results of the dynamic scan correlated better with eventual patient outcome than the presence or absence of arteriographic spasm. It is therefore suggested that patients in Grades I and II with normal dynamic scans be operated on promptly to prevent rebleeding, and that surgery in patients in Grades I and II with abnormal dynamic scans be delayed until the dynamic scan returns to normal.

Entities:  

Mesh:

Year:  1977        PMID: 864506     DOI: 10.3171/jns.1977.47.1.0044

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

Review 1.  CT perfusion cerebral blood flow imaging in neurological critical care.

Authors:  Mark R Harrigan; Jody Leonardo; Kevin J Gibbons; Lee R Guterman; L Nelson Hopkins
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 2.  Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.

Authors:  Darcy Lidington; Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

3.  Anti-phospholipid antibodies and cerebral vasospasm following subarachnoid haemorrhage.

Authors:  Y Hirashima; M Kurimoto; E Tsukamoto; S Endo; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  Early effects of experimental arterial subarachnoid haemorrhage on the cerebral circulation. Part I: Experimental subarachnoid haemorrhage in cat and its pathophysiological effects. Methods of regional cerebral blood flow measurement and evaluation of microcirculation.

Authors:  T Trojanowski
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

5.  Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage.

Authors:  Y Hirashima; S Endo; M Kurimoto; E Tsukamoto; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

6.  Value of electroencephalography (EEG) before and after surgery of intracranial aneurysms.

Authors:  H E Nau; W J Bock
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

7.  Cortical blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage: three-dimensional N-isopropyl-p-[(123)I]iodoamphetamine single photon emission CT findings.

Authors:  Hiroki Ohkuma; Shigeharu Suzuki; Kanae Kudo; Shafiqul Islam; Tomonari Kikkawa
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

8.  Reliability of CT Angiography in Cerebral Vasospasm: A Systematic Review of the Literature and an Inter- and Intraobserver Study.

Authors:  L Letourneau-Guillon; B Farzin; T E Darsaut; M Kotowski; F Guilbert; M Chagnon; A Diouf; D Roy; A Weill; M Lemus; C Bard; M Belair; D Landry; L Nico; A Tellier; R Jabre; C Kauffmann; J Raymond
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-26       Impact factor: 3.825

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.